Celiac Disease pp 137-159 | Cite as

Dietary Supplements in Celiac Disease

  • Michelle Maria Pietzak
Part of the Clinical Gastroenterology book series (CG)


Celiac disease (CD) is an immune-mediated disorder that occurs in genetically predisposed individuals who ingest gluten. Gluten is a dietary protein found in wheat, barley, and rye. In the susceptible person, this gluten-containing diet can lead to the development of an autoimmune enteropathy, causing malabsorption of carbohydrates, proteins, fats, and critical vitamins and minerals. Deficiencies of key nutrients in celiac disease occur due to malabsorption, poor dietary intake, and lack of fortification of gluten-free foodstuff. This chapter reviews the data regarding common dietary supplements that may enhance a healthy gluten-free lifestyle, including iron, B-complex vitamins, fat-soluble vitamins, trace metals and minerals, fiber, and probiotics. Special attention is given to dietary supplements that promote bone health, pregnancy, and fertility, and alleviate symptoms in refractory celiac disease (RCD). Clinicians must maintain a high index of suspicion for these nutritional deficiencies, as they may present with a myriad of symptoms that closely mimic other disorders. If diagnosed early, the nutritional complications of long-standing celiac disease can be completely avoided by strict adherence to the gluten-free diet and appropriate dietary supplements.


Folic Acid Irritable Bowel Syndrome Celiac Disease Copper Deficiency Celiac Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rubin CE, Brandborg LL, Flick AL. Biopsy studies on the pathogenesis of celiac sprue. In: Wolstenholme GEW, Cameron CM, editors. Intestinal biopsy. Boston: Little, Brown & Co; 1962. p. 67.Google Scholar
  2. 2.
    Lee SK, Lo W, Memeo L, Rotterdam H, Green PH. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc. 2003;57:187–91.PubMedGoogle Scholar
  3. 3.
    Hankey GL, Holmes GK. Coeliac disease in the elderly. Gut. 1994;35:65–7.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Pietzak M. The follow-up of patients with celiac disease – achieving compliance with treatment. Gastroenterology. 2005;128:S135–41.PubMedGoogle Scholar
  5. 5.
    Ljungman G, Myrdal U. Compliance in teenagers with coeliac disease—a Swedish follow-up study. Acta Paediatr. 1993;82:235–8.PubMedGoogle Scholar
  6. 6.
    Mäki M, Lähdehaho ML, Hällström O, Viander M, Visakorpi JK. Postpubertal gluten challenge in coeliac disease. Arch Dis Child. 1989;64:1604–7.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Carroccio A, Iannitto E, Cavataio F, Montalto G, Tumminelo M, Campagna P, et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci. 1998;43:673–8.PubMedGoogle Scholar
  8. 8.
    Wessling-Resnick M. Iron transport. Annu Rev Nutr. 2000;20:129–51.PubMedGoogle Scholar
  9. 9.
    Harper JW, Holleran SF, Ramakrishnan R, Bhagat G, Green PHR. Anemia in celiac disease is multifactorial in etiology. Am J Hematol. 2007;11:996–1000.Google Scholar
  10. 10.
    Thompson T, Dennis M, Higgins LA, Lees AR, Sharrett MK. Gluten-free diet survey: are Americans with celiac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Dietet. 2005;18:163–9.Google Scholar
  11. 11.
    Thompson T. Folate, iron, and dietary fiber contents of the gluten-free diet. J Am Diet Assoc. 2000;100:1389–96.PubMedGoogle Scholar
  12. 12.
    Shepherd SJ, Gibson PR. Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease. J Hum Nutr Diet. 2012. doi: 10.1111/jhn.12018.PubMedGoogle Scholar
  13. 13.
    Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.Google Scholar
  14. 14.
    Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest. 1964;43(2):247.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Carroccio A, Iacono G, Lerro P, Cavataio F, Malorgio E, Soresi M, et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology. 1997;112:1839–44.PubMedGoogle Scholar
  16. 16.
    Ross CA. Vitamin A. In: Coates PM, Betz JM, Blackman MR, editors. Encyclopedia of dietary supplements. 2nd ed. London: Informa Healthcare; 2010. p. 778–91.Google Scholar
  17. 17.
    Alberts D, Ranger-Moore J, Einspahr J. Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin. Clin Cancer Res. 2004;10:1875–80.PubMedGoogle Scholar
  18. 18.
    National Institutes of Health, Office of Dietary Supplements. Facts about dietary supplements: vitamin A and carotenoids. Bethesda: National Institutes of Health; December 2001.Google Scholar
  19. 19.
    Ribaya-Mercado JD, Blumber JB. Vitamin A: is it a risk factor for osteoporosis and bone fracture? Nutr Rev. 2007;65(10):425–38.PubMedGoogle Scholar
  20. 20.
    Sommer A. Vitamin A, deficiency and clinical disease: an historical overview. J Nutr. 2008;138:1835–9.PubMedGoogle Scholar
  21. 21.
    World Health Organization. Global prevalence of vitamin A deficiency in populations at risk 1995–2005: WHO global database on vitamin A deficiency. Geneva: World Health Organization; 2009.Google Scholar
  22. 22.
    Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.Google Scholar
  23. 23.
    Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, et al. Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev. 2009;18:2202–6.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–36.PubMedCentralGoogle Scholar
  25. 25.
    Ross A. Vitamin A and carotenoids. In: Shils M, Shike M, Ross A, Caballero B, Cousins R, editors. Modern nutrition in health and disease. 10th ed. Baltimore: Lippincott Williams & Wilkins; 2006. p. 351–75.Google Scholar
  26. 26.
    Villamor E, Fawzi WW. Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis. 2000;182 Suppl 1:S122–33.PubMedGoogle Scholar
  27. 27.
    Traber MG. Vitamin E. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins R, editors. Modern nutrition in health and disease. 10th ed. Baltimore: Lippincott Williams & Wilkins; 2006. p. 396–411.Google Scholar
  28. 28.
    Kowdley KV, Mason JB, Meydani SN, Cornwall S, Grand RJ. Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption. Gastroenterology. 1992;102:2139–42.PubMedGoogle Scholar
  29. 29.
    Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180–9.PubMedGoogle Scholar
  30. 30.
    Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, et al. Supplemental and dietary vitamin E, β-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006;98:245–54.PubMedGoogle Scholar
  31. 31.
    Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, et al. Reduced risk of colon cancer with high intakes of vitamin E: the Iowa women’s health study. Cancer Res. 1993;15:4230–17.Google Scholar
  32. 32.
    Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol. 2002;156:1002–10.PubMedGoogle Scholar
  33. 33.
    Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Opthalmol. 2011;119:1439–52.Google Scholar
  34. 34.
    Sokol RJ, Guggenheim MA, Heubi JE. Frequency and clinical progression of the vitamin E deficiency neurologic disorder in children with prolonged neonatal cholestasis. Am J Dis Child. 1985;139(12):1211–5.PubMedGoogle Scholar
  35. 35.
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57.PubMedGoogle Scholar
  36. 36.
    Dietrich M, Traber MG, Jacques PF, Cross CE, Hu Y, Block G. Does γ-tocopherol play a role in the primary prevention of heart disease and cancer? A review. Am J Coll Nutr. 2006;25:292–9.Google Scholar
  37. 37.
    Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press; 2010.Google Scholar
  38. 38.
    Wharton B, Bishop N. Rickets. Lancet. 2003;362:1389–400.PubMedGoogle Scholar
  39. 39.
    Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–3.PubMedGoogle Scholar
  40. 40.
    Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29:650–6.PubMedGoogle Scholar
  41. 41.
    Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352:709–10.PubMedGoogle Scholar
  42. 42.
    Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–5.PubMedGoogle Scholar
  43. 43.
    Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832–8.PubMedGoogle Scholar
  44. 44.
    Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag K. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa women’s health study. Arthritis Rheum. 2004;50:72–7.PubMedGoogle Scholar
  45. 45.
    Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med. 2005;352(5):515–6.PubMedGoogle Scholar
  46. 46.
    Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004;80:1710S–6S.PubMedGoogle Scholar
  47. 47.
    LeBlanc ES, Perrin N, Johnson JD, Ballatore A, Hillier T. Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med. 2013;173(7):585–6.PubMedGoogle Scholar
  48. 48.
    Udall JA. Human sources and absorption of vitamin K in relation to anticoagulation stability. JAMA. 1965;194(2):127–9.PubMedGoogle Scholar
  49. 49.
    Ozdemir MA, Karakukcu M, Per H, Unal E, Gumus H, Patiroglu T. Late-type vitamin K deficiency bleeding: experience from 120 patients. Childs Nerv Syst. 2012;28(2):247–51.PubMedGoogle Scholar
  50. 50.
    Vermeer C, Theuwissen E. Vitamin K, osteoporosis and degenerative diseases of ageing. Menopause Int. 2011;17(1):19–23.PubMedGoogle Scholar
  51. 51.
    Krasinski SD, Russell RM, Furie BC. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985;41(3):639–43.PubMedGoogle Scholar
  52. 52.
    Suttie JW. Vitamin K. In: Machlin L, editor. Handbook of vitamins. New York: Marcel Dekker; 1984. p. 147.Google Scholar
  53. 53.
    Sdepanian VL, de Miranda Carvalho CN, de Morais MB, Colugnati FA, Fagundes-Neto U. Bone mineral density of the lumbar spine in children and adolescents with celiac disease on a gluten-free diet in São Paulo, Brazil. J Pediatr Gastroenterol Nutr. 2003;37(5):571–6.PubMedGoogle Scholar
  54. 54.
    Krebs NF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr. 2000;130:1374S–7S.PubMedGoogle Scholar
  55. 55.
    Singhal N, Alam S, Sherwani R, Musarrat J. Serum zinc levels in celiac disease. Indian Pediatr. 2008;45(4):319–21.PubMedGoogle Scholar
  56. 56.
    Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr. 1976;29(4):371–5.PubMedGoogle Scholar
  57. 57.
    Lazebnik N, Kuhnert BR, Kuhnert PM, Thompson KL. Zinc status, pregnancy complications, and labor abnormalities. Am J Obstet Gynecol. 1988;158(1):161–6.PubMedGoogle Scholar
  58. 58.
    Tran CD, Katsikeros R, Manton N, Krebs NF, Hambidge KM, Butler RN, et al. Zinc homeostasis and gut function in children with celiac disease. Am J Clin Nutr. 2011;94(4):1026–32.PubMedGoogle Scholar
  59. 59.
    Lonnerdal B. Dietary factors influencing zinc absorption. J Nutr. 2000;130:1378S–85S.PubMedGoogle Scholar
  60. 60.
    Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors? Scand J Gastroenterol. 1998;33:1057–61.PubMedGoogle Scholar
  61. 61.
    National Institutes of Health Office of Dietary Supplements. Dietary Supplement Fact Sheet: Selenium.
  62. 62.
    Stazi AV, Trinti B. Selenium deficiency in celiac disease: risk of autoimmune thyroid diseases [Article in Italian]. Minerva Med. 2008;99(6):643–53.PubMedGoogle Scholar
  63. 63.
    Brown JS, Foster HD. Schizophrenia: an update of the selenium deficiency hypothesis. J Orthomol Med. 1996;11(400):211–2.Google Scholar
  64. 64.
    Longnecker MP, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr. 1991;53:1288–94.PubMedGoogle Scholar
  65. 65.
    Koller LD, Exon JH. The two faces of selenium-deficiency and toxicity are similar in animals and man. Can J Vet Res. 1986;50:297–306.PubMedCentralPubMedGoogle Scholar
  66. 66.
    Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003;38:232–42.PubMedGoogle Scholar
  67. 67.
    Halfdanarson TR, Kumar N, Hogan WJ, Murray JA. Copper deficiency in celiac disease. J Clin Gastroenterol. 2009;43(2):162–4.PubMedGoogle Scholar
  68. 68.
    Goodman PB, Mistry MD. Copper deficiency myeloneuropathy due to occult celiac disease. Neurologist. 2009;15(6):355–6.PubMedGoogle Scholar
  69. 69.
    Hedera P, Peltier A, Fink JK, Wilcock S, London Z, Brewer GJ. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc. Neurotoxicology. 2009 Nov;30(6):996–9.PubMedGoogle Scholar
  70. 70.
    Kopic S, Geibel JP. Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev. 2013;93(1):189–268.PubMedGoogle Scholar
  71. 71.
    Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–53.PubMedGoogle Scholar
  72. 72.
    Krittaphol W, Bailey KB, Pongcharoen T, Winichagoon P, Gibson RS. Low zinc, iron, and calcium intakes of Northeast Thai school children consuming glutinous rice-based diets are not exacerbated by high phytate. Int J Food Sci Nutr. 2006;57(7–8):520–8.PubMedGoogle Scholar
  73. 73.
    Thomas E, von Unruh GE, Hesse A. Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion. Eur J Clin Nutr. 2008;62(9):1090–7.PubMedGoogle Scholar
  74. 74.
    Legrand SB. Modern management of malignant hypercalcemia. Am J Hosp Palliat Care. 2011;28(7):515–7.PubMedGoogle Scholar
  75. 75.
    Rujner J, Socha J, Syczewska M, Wojtasik A, Kunachowicz H, Stolarczyk A. Magnesium status in children and adolescents with coeliac disease without malabsorption symptoms. Clin Nutr. 2004;5:1074–9.Google Scholar
  76. 76.
    Wild D, Robins GG, Burley VJ, Howdle PD. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther. 2010;32(4):573–81.PubMedGoogle Scholar
  77. 77.
    al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994;24(5):737–52.PubMedGoogle Scholar
  78. 78.
    Ramsay JG. Cardiac management in the ICU. Chest. 1999;115(5):138S–44S.PubMedGoogle Scholar
  79. 79.
    Horn EJ. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010;56(1):112–6.Google Scholar
  80. 80.
    Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56(4):931–50.PubMedGoogle Scholar
  81. 81.
    Thompson T, Lee AR, Grace T. Gluten contamination of grains, seeds, and flours in the United States: a pilot study. J Am Diet Assoc. 2010;110(6):937–40.PubMedGoogle Scholar
  82. 82.
    Pietzak M. Gluten-free food labeling in the United States. J Pediatr Gastroenterol Nutr. 2005;41(5):567–8.PubMedGoogle Scholar
  83. 83.
    Holmes G, Catassi C, editors. Coeliac disease. Oxford: Health Press; 2000.Google Scholar
  84. 84.
    Hoffenberg EJ, Haas J, Drescher A, Barnhurst R, Osberg I, Bao F, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr. 2000;137:361–6.PubMedGoogle Scholar
  85. 85.
    D’Arienzo R, Stefanile R, Maurano F, Mazzarella G, Ricca E, Troncone R, et al. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand J Immunol. 2011;74(4):335–41.PubMedGoogle Scholar
  86. 86.
    Mennigen R, Bruewer M. Effect of probiotics on intestinal barrier function molecular structure and function of the tight junction. Ann NY Acad Sci. 2009;1165:183–9.PubMedGoogle Scholar
  87. 87.
    De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Bioenergetics. 2006;1762(1):80–93.Google Scholar
  88. 88.
    Papista C, Gerakopoulos V, Kourelis A, Sounidaki M, Kontana A, Berthelot L, et al. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Lab Invest. 2012;92(4):625–35.PubMedGoogle Scholar
  89. 89.
    Fouda MA, Khan AA, Sultan MS, Rios LP, McAssey K, Armstrong D. Evaluation and management of skeletal health in celiac disease: position statement. [Review]. Can J Gastroenterol. 2012;26(11):819–29.PubMedCentralPubMedGoogle Scholar
  90. 90.
    Valdimarsson T, Lofmano O, Toss G, Strom M. Reversal of osteopenia with diet in adult coeliac disease. Gut. 1996;38:322–7.PubMedCentralPubMedGoogle Scholar
  91. 91.
    Mora S, Barera G, Beccio S, Proverbio MC, Weber G, Bianchi C, et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol. 1999;94:398–403.PubMedGoogle Scholar
  92. 92.
    Prader A, Tanner JM, von Harnack GA. Catch-up growth in coeliac disease. Acta Paediatr Scand. 1969;58:311.Google Scholar
  93. 93.
    Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol. 2001;96:112–9.PubMedGoogle Scholar
  94. 94.
    Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med. 2005;165:393–9.PubMedGoogle Scholar
  95. 95.
    Valdimarsson T, Toss G, Löfman O, Ström M. Three years’ follow-up of bone density in adult coeliac disease: significance of secondary hyperparathyroidism. Scand J Gastroenterol. 2000;35:274–80.PubMedGoogle Scholar
  96. 96.
    Mora S, Barera G, Beccio S, Menni L, Proverbio MC, Bianchi C, et al. A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr. 2001;139:516–21.PubMedGoogle Scholar
  97. 97.
    Sategna-Guidetti C, Grosso SB, Grosso S, Mengozzi G, Aimo G, Zaccaria T, et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther. 2000;14:35–43.PubMedGoogle Scholar
  98. 98.
    Recker RR, Armas L. The effect of antiresorptives on bone quality. Clin Orthop Relat Res. 2011;469(8):2207–14.PubMedCentralPubMedGoogle Scholar
  99. 99.
    Danowski L, Brand LG, Connolly J. Selections from current literature: gluten-free diets, coeliac disease and associated disorders. Fam Pract. 2003;20:607–11.PubMedGoogle Scholar
  100. 100.
    Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S. Prevalence of celiac disease in at-risk and not at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–92.PubMedGoogle Scholar
  101. 101.
    Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Acta Paediatr Suppl. 1996;412:76–7.PubMedGoogle Scholar
  102. 102.
    Ciacci C, Cirillo M, Auriemma G, Di Dato G, Sabbatini F, Mazzacca G. Celiac disease and pregnancy outcome. Am J Gastroenterol. 1996;91:718–22.PubMedGoogle Scholar
  103. 103.
    Wald NJ, Hackshaw AD, Stone R. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol. 1996;103(4):319–24.PubMedGoogle Scholar
  104. 104.
    Kumar A, Meena M, Begum N, Kumar N, Gupta RK, Aggarwal S, et al. Latent celiac disease in reproductive performance of women. Fertil Steril. 2011;95(3):922–7.PubMedGoogle Scholar
  105. 105.
    Zerfu TA, Ayele KT. Micronutrients and pregnancy; effect of supplementation on pregnancy and pregnancy outcomes: a systematic review. Nutr J. 2013;12:20.PubMedCentralPubMedGoogle Scholar
  106. 106.
    Hancock R, Koren G. Celiac disease during pregnancy. Can Fam Physician. 2004;50:1361–3.PubMedCentralPubMedGoogle Scholar
  107. 107.
    Daum S, Cellier C, Mulder CJJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413–24.PubMedGoogle Scholar
  108. 108.
    Stuart BM, Gent AE. Atrophy of the coeliac mucosa. Eur J Gastroenterol Hepatol. 1998;10:523–5.PubMedGoogle Scholar
  109. 109.
    Mitchison HC, al Mardini H, Gillespie S. A pilot study of fluticasone propionate in untreated coeliac disease. Gut. 1991;32:260–5.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Vaidya A, Bolanos J, Berkelhammer C. Azathioprine in refractory sprue. Am J Gastroenterol. 1999;94:1967–9.PubMedGoogle Scholar
  111. 111.
    Rolny P, Sigurjonsdottir HA, Remotti H. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol. 1999;94:219–25.PubMedGoogle Scholar
  112. 112.
    O’Mahony S, Howdle PD, Losowsky SM. Management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671–80.PubMedGoogle Scholar
  113. 113.
    Mulder CJ, Wahab PJ, Moshaver B, Meijer JW. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol Suppl. 2000;232:32–7.PubMedGoogle Scholar
  114. 114.
    Love A, Elmes M, Golden M, McMaster D. Zinc deficiency and coeliac disease. In: McNicholl B, McCarthy C, Fottrell P, editors. Perspectives in coeliac disease. Lancaster: MTP; 1978. p. 335–42.Google Scholar
  115. 115.
    Olaussen RW, Løvik A, Tollefsen S, Andresen PA, Vatn MH, De Lange T, et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol. 2005;3(9):875–85.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Pediatric GastroenterologyUniversity of Southern California Keck School of MedicineLos AngelesUSA

Personalised recommendations